Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM

Biophysical Journal

Volumn 108, Issue 5, 2015, Pages 1013-1026

  Coban, Oana ^a,b   Zanetti Dominguez, Laura C ^c   Matthews, Daniel R ^a,b   Rolfe, Daniel J ^c   Weitsman, Gregory ^a,b   Barber, Paul R ^d   Barbeau, Jody ^a,b   Devauges, Viviane ^a,b   Kampmeier, Florian ^e   Winn, Martyn ^c   Vojnovic, Borivoj ^b,d   Parker, Peter J ^a,f   Lidke, Keith A ^g   Lidke, Diane S ^h,i   Ameer Beg, Simon M ^a,b   Martin Fernandez, Marisa L ^c   Ng, Tony ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c RUTHERFORD APPLETON LABORATORY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^g UNIVERSITY OF NEW MEXICO   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

CHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING; PROTEIN STABILITY; TUMOR CELL LINE;

CELL LINE, TUMOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3;

EID: 84924794896     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2015.01.005     Document Type: Article

References (87)

1. J. Schlessinger Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110 2002 669 672
2. G. Carpenter, C.M. Stoscheck, and A.M. Soderquist Epidermal growth factor Ann. N. Y. Acad. Sci. 397 1982 11 17
3. A. Kumar, and E.T. Petri T.J. Boggon Structure and clinical relevance of the epidermal growth factor receptor in human cancer J. Clin. Oncol. 26 2008 1742 1751
4. J.S. Ross, and J.A. Fletcher The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Stem Cells 16 1998 413 428
5. G. Selvaggi, and S. Novello G.V. Scagliotti Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann. Oncol. 15 2004 28 32
6. H. Ogiso, and R. Ishitani S. Yokoyama Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains Cell 110 2002 775 787
7. M.A. Lemmon, and J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 141 2010 1117 1134
8. K.M. Ferguson Active and inactive conformations of the epidermal growth factor receptor Biochem. Soc. Trans. 32 2004 742 745
9. T. Moriki, H. Maruyama, and I.N. Maruyama Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain J. Mol. Biol. 311 2001 1011 1026
10. A.H. Clayton, and F. Walker A.W. Burgess Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis J. Biol. Chem. 280 2005 30392 30399
11. M.A. Lemmon, and Z. Bu J. Schlessinger Two EGF molecules contribute additively to stabilization of the EGFR dimer EMBO J. 16 1997 281 294
12. N. Jura, and N.F. Endres J. Kuriyan Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment Cell 137 2009 1293 1307
13. X. Zhang, and J. Gureasko J. Kuriyan An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor Cell 125 2006 1137 1149
14. D. Alvarado, D.E. Klein, and M.A. Lemmon Structural basis for negative cooperativity in growth factor binding to an EGF receptor Cell 142 2010 568 579
15. T.P. Garrett, and N.M. McKern C.W. Ward The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors Mol. Cell 11 2003 495 505
16. T.P. Garrett, and N.M. McKern C.W. Ward Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α Cell 110 2002 763 773
17. K.M. Ferguson Structure-based view of epidermal growth factor receptor regulation Annu. Rev. Biophys. 37 2008 353 373
18. J. Stamos, M.X. Sliwkowski, and C. Eigenbrot Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor J. Biol. Chem. 277 2002 46265 46272
19. E.R. Wood, and A.T. Truesdale L. Shewchuk A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells Cancer Res. 64 2004 6652 6659
20. C.H. Yun, and T.J. Boggon M.J. Eck Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity Cancer Cell 11 2007 217 227
21. M. Red Brewer, and S.H. Choi G. Carpenter The juxtamembrane region of the EGF receptor functions as an activation domain Mol. Cell 34 2009 641 651
22. A.W. Burgess, and H.S. Cho S. Yokoyama An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol. Cell 12 2003 541 552
23. A. Dixit, and G.M. Verkhivker Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations PLOS Comput. Biol. 5 2009 e1000487
24. S.T. Low-Nam, and K.A. Lidke D.S. Lidke ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding Nat. Struct. Mol. Biol. 18 2011 1244 1249
25. M. Hiroshima, and Y. Saeki Y. Sako Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells Proc. Natl. Acad. Sci. USA 109 2012 13984 13989
26. Y. Teramura, and J. Ichinose Y. Sako Single-molecule analysis of epidermal growth factor binding on the surface of living cells EMBO J. 25 2006 4215 4222
27. S.E. Webb, and S.K. Roberts M.L. Martin-Fernandez Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells Biophys. J. 94 2008 803 819
28. C. Yu, and J. Hale J. Irudayaraj Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from real-time single molecule analysis Biochem. Biophys. Res. Commun. 378 2009 376 382
29. N. Kawashima, and K. Nakayama V. Biju Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots Chemistry 16 2010 1186 1192
30. Y. Sako, S. Minoghchi, and T. Yanagida Single-molecule imaging of EGFR signalling on the surface of living cells Nat. Cell Biol. 2 2000 168 172
31. Z. Xiao, and W. Zhang X. Fang Single-molecule diffusion study of activated EGFR implicates its endocytic pathway Biochem. Biophys. Res. Commun. 369 2008 730 734
32. J. Chen, and J. Irudayaraj Fluorescence lifetime cross correlation spectroscopy resolves EGFR and antagonist interaction in live cells Anal. Chem. 82 2010 6415 6421
33. I. Vivanco, and H.I. Robins I.K. Mellinghoff Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors Cancer Discov. 2 2012 458 471
34. E.M. Bublil, and G. Pines Y. Yarden Kinase-mediated quasi-dimers of EGFR FASEB J. 24 2010 4744 4755
35. C. Lu, and L.-Z. Mi T.A. Springer Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor J. Biol. Chem. 287 2012 38244 38253
36. H. Shankaran, H.S. Wiley, and H. Resat Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response Biophys. J. 90 2006 3993 4009
37. H. Shankaran, and Y. Zhang H. Resat Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking Biochem. Biophys. Res. Commun. 371 2008 220 224
38. M. Mustafa, A. Mirza, and N. Kannan Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study Proteins 79 2011 99 114
39. J.H. Park, and Y. Liu R. Radhakrishnan Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain Biochem. J. 448 2012 417 423
40. B.D. Harms, and J.D. Kearns B. Schoeberl Optimizing properties of antireceptor antibodies using kinetic computational models and experiments Methods Enzymol. 502 2012 67 87
41. B. Schoeberl, and C. Eichler-Jonsson G. Müller Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors Nat. Biotechnol. 20 2002 370 375
42. A. Arkhipov, and Y. Shan D.E. Shaw Architecture and membrane interactions of the EGF receptor Cell 152 2013 557 569
43. U.B. Nielsen, and B. Schoeberl Using computational modeling to drive the development of targeted therapeutics IDrugs. 8 2005 822 826
44. M.M. Pryor, and S.T. Low-Nam J.S. Edwards Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling Biophys. J. 105 2013 1533 1543
45. G. Tarcic, and S.K. Boguslavsky Y. Yarden An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis Curr. Biol. 19 2009 1788 1798
46. A.F. Gazdar, and V. Kurvari J.W. Shay Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer Int. J. Cancer. 78 1998 766 774
47. T. Kiuchi, and E. Ortiz-Zapater T. Ng The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility Sci. Signal. 7 2014 ra78
48. F. Kampmeier, and J. Niesen T. Thepen Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein Eur. J. Nucl. Med. Mol. Imaging 37 2010 1926 1934
49. P.R. Barber, and I.D. Tullis B. Vojnovic The Gray Institute 'open' high-content, fluorescence lifetime microscopes J. Microsc. 251 2013 154 167
50. P.R. Barber, and S.M. Ameer-Beg B. Vojnovic Multiphoton time-domain fluorescence lifetime imaging microscopy: practical application to protein-protein interactions using global analysis J. R. Soc. Interface 6 2009 S93 S105
51. T. Ng, and A. Squire P.J. Parker Imaging protein kinase Cα activation in cells Science 283 1999 2085 2089
52. J.R. Morris, and C. Boutell E. Solomon The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress Nature 462 2009 886 890
53. L.M. Carlin, and R. Evans T. Ng A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse Sci. Signal. 4 2011 ra81
54. G.O. Fruhwirth, and L.P. Fernandes T. Ng How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology ChemPhysChem 12 2011 442 461
55. H.P. Lu, L. Xun, and X.S. Xie Single-molecule enzymatic dynamics Science 282 1998 1877 1882
56. W.H. Press, and S.A. Teukolsky B.P. Flannery Numerical Recipes in C 1992 Cambridge University Press Cambridge
57. N.L. Andrews, and K.A. Lidke D.S. Lidke Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization Nat. Cell Biol. 10 2008 955 963
58. M.P. Steinkamp, and S.T. Low-Nam B.S. Wilson erbB3 is an active tyrosine kinase capable of homo- and heterointeractions Mol. Cell. Biol. 34 2014 965 977
59. D.J. Rolfe, and C.I. McLachlan M.P. Hobson Automated multidimensional single molecule fluorescence microscopy feature detection and tracking Eur. Biophys. J. 40 2011 1167 1186
60. P.R. Barber, and S.M. Ameer-Beg B. Vojnovic Global and pixel kinetic data analysis for FRET detection by multi-photon time-domain FLIM Proc. SPIE. 5700 2005 171 181
61. D. Shu, and H. Zhang P. Guo Counting of six pRNAs of phi29 DNA-packaging motor with customized single-molecule dual-view system EMBO J. 26 2007 527 537
62. O. Coban, and D.C. Lamb G.U. Nienhaus Conformational heterogeneity in RNA polymerase observed by single-pair FRET microscopy Biophys. J. 90 2006 4605 4617
63. L.H. Defize, and D.J. Arndt-Jovin S.W. de Laat A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover J. Cell Biol. 107 1988 939 949
64. L.H. Defize, and J. Boonstra S.W. de Laat Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors J. Cell Biol. 109 1989 2495 2507
65. 2+ signaling: single-molecule tracking study 2 J. Cell Biol. 177 2007 731 742
66. L.C. Zanetti-Domingues, and C.J. Tynan M. Martin-Fernandez Hydrophobic fluorescent probes introduce artifacts into single molecule tracking experiments due to non-specific binding PLoS ONE 8 2013 e74200
67. K.G. Suzuki, and R.S. Kasai A. Kusumi Transient GPI-anchored protein homodimers are units for raft organization and function Nat. Chem. Biol. 8 2012 774 783
68. M. Offterdinger, and V. Georget P.I. Bastiaens Imaging phosphorylation dynamics of the epidermal growth factor receptor J. Biol. Chem. 279 2004 36972 36981
69. A.R. Reynolds, and C. Tischer P.I. Bastiaens EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation Nat. Cell Biol. 5 2003 447 453
70. X. Zhang, and K.A. Pickin J. Kuriyan Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface Nature 450 2007 741 744
71. H. Zhang, and A. Berezov M.I. Greene ErbB receptors: from oncogenes to targeted cancer therapies J. Clin. Invest. 117 2007 2051 2058
72. T.R. Wilson, and J. Fridlyand J. Settleman Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature 487 2012 505 509
73. C.J. Tsai, and R. Nussinov The molecular basis of targeting protein kinases in cancer therapeutics Semin. Cancer Biol. 23 2013 235 242
74. L.F. Stead, and K.M. Sutton P. Rabbitts Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution Hum. Mutat. 34 2013 1432 1438
75. R.A. Burrell, and N. McGranahan C. Swanton The causes and consequences of genetic heterogeneity in cancer evolution Nature 501 2013 338 345
76. M. Gerlinger, and A.J. Rowan C. Swanton Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
77. T.J. Lynch, and D.W. Bell D.A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
78. J.G. Paez, and P.A. Jänne M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
79. W. Pao, and J. Chmielecki Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer Nat. Rev. Cancer 10 2010 760 774
80. N. Jura, and Y. Shan J. Kuriyan Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 Proc. Natl. Acad. Sci. USA 106 2009 21608 21613
81. A. Citri, and Y. Yarden EGF-ERBB signalling: towards the systems level Nat. Rev. 7 2006 505 516
82. K. Oda, Y. Matsuoka, A. Funahashi, and H. Kitano A comprehensive pathway map of epidermal growth factor receptor signaling Mol. Syst. Biol. 1 2005 2005.0010
83. J. Ichinose, and M. Murata Y. Sako EGF signalling amplification induced by dynamic clustering of EGFR Biochem. Biophys. Res. Commun. 324 2004 1143 1149
84. J.L. Macdonald, and L.J. Pike Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system Proc. Natl. Acad. Sci. USA 105 2008 112 117
85. J.L. Macdonald-Obermann, and L.J. Pike The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding J. Biol. Chem. 284 2009 13570 13576
86. Z. Hartman, H. Zhao, and Y.M. Agazie HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling Oncogene 32 2013 4169 4180
87. D.M. Hickinson, and T. Klinowska D. Ogilvie AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer Clin. Cancer Res. 16 2010 1159 1169